Report Detail
Global Induced Pluripotent Stem Cells Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4719650 |
- 29 June, 2026 |
- Global |
- 113 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Induced Pluripotent Stem Cells Service market size was valued at US$ 3317 million in 2025 and is forecast to a readjusted size of US$ 6485 million by 2032 with a CAGR of 10.2% during review period.
Induced pluripotent stem cell (iPSC) services refer to a series of professional technologies and processes designed to reprogram pluripotent stem cells from adult cells (such as skin or blood cells). These cells can self-renew and differentiate into a variety of cell types, and have a wide range of application potential, including regenerative medicine, drug screening, and disease model construction. iPSC manufacturing services are the core of iPSC services, including the selection of cell sources and the implementation of cell reprogramming. Through precise induction technology, researchers can convert mature somatic cells into iPSCs. iPSC reprogramming services focus on using various methods (such as viral vectors, transfection, or small molecule compounds) to achieve cell reprogramming. These methods can effectively improve the efficiency of reprogramming and the safety of cells. Once iPSCs are generated, iPSC culture services become key. This service ensures that iPSCs grow under optimal conditions, maintain their pluripotency, and avoid differentiation. Next, iPSC differentiation services can be used to induce iPSCs to differentiate into specific cell types, such as neurons, cardiomyocytes, etc., to meet research and treatment needs. In addition, iPSC gene editing services enable researchers to make precise gene modifications in iPSCs, facilitating the study of gene function, disease mechanisms, and the development of personalized treatment plans. In summary, induced pluripotent stem cell services cover multiple aspects such as iPSC manufacturing, reprogramming, culture, differentiation, and gene editing, providing strong support for regenerative medicine and biomedical research.
This report is a detailed and comprehensive analysis for global Induced Pluripotent Stem Cells Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Induced Pluripotent Stem Cells Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Induced Pluripotent Stem Cells Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Induced Pluripotent Stem Cells Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Induced Pluripotent Stem Cells Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Induced Pluripotent Stem Cells Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Induced Pluripotent Stem Cells Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Thermo Fisher Scientific Inc., FUJIFILM Cellular Dynamics, Inc. (FCDI), Charles River Laboratories, Novo Holdings (Catalent, Inc), Creative Bioarray, Creative Biolabs, iXCells Biotechnologies, Creative Biogene, Axol Bioscience Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Induced Pluripotent Stem Cells Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
iPSC Manufacturing Service
iPSC Reprogramming Service
iPSC Culture Service
iPSC Differentiation Service
iPSC Gene Editing Service
Other
Market segment by Application
Pharmaceutical Company
Laboratory
Scientific Research Institution
Market segment by players, this report covers
Lonza
Thermo Fisher Scientific Inc.
FUJIFILM Cellular Dynamics, Inc. (FCDI)
Charles River Laboratories
Novo Holdings (Catalent, Inc)
Creative Bioarray
Creative Biolabs
iXCells Biotechnologies
Creative Biogene
Axol Bioscience Ltd.
Elixirgen Scientific, Inc.
Cyagen
ALSTEM
uBriGene Biosciences International Co.
NEXEL Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Induced Pluripotent Stem Cells Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Induced Pluripotent Stem Cells Service, with revenue, gross margin, and global market share of Induced Pluripotent Stem Cells Service from 2021 to 2026.
Chapter 3, the Induced Pluripotent Stem Cells Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Induced Pluripotent Stem Cells Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Induced Pluripotent Stem Cells Service.
Chapter 13, to describe Induced Pluripotent Stem Cells Service research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Induced Pluripotent Stem Cells Service by Type
- 1.3.1 Overview: Global Induced Pluripotent Stem Cells Service Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Induced Pluripotent Stem Cells Service Consumption Value Market Share by Type in 2025
- 1.3.3 iPSC Manufacturing Service
- 1.3.4 iPSC Reprogramming Service
- 1.3.5 iPSC Culture Service
- 1.3.6 iPSC Differentiation Service
- 1.3.7 iPSC Gene Editing Service
- 1.3.8 Other
- 1.4 Global Induced Pluripotent Stem Cells Service Market by Application
- 1.4.1 Overview: Global Induced Pluripotent Stem Cells Service Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical Company
- 1.4.3 Laboratory
- 1.4.4 Scientific Research Institution
- 1.5 Global Induced Pluripotent Stem Cells Service Market Size & Forecast
- 1.6 Global Induced Pluripotent Stem Cells Service Market Size and Forecast by Region
- 1.6.1 Global Induced Pluripotent Stem Cells Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Induced Pluripotent Stem Cells Service Market Size by Region, (2021-2032)
- 1.6.3 North America Induced Pluripotent Stem Cells Service Market Size and Prospect (2021-2032)
- 1.6.4 Europe Induced Pluripotent Stem Cells Service Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size and Prospect (2021-2032)
- 1.6.6 South America Induced Pluripotent Stem Cells Service Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Lonza
- 2.1.1 Lonza Details
- 2.1.2 Lonza Major Business
- 2.1.3 Lonza Induced Pluripotent Stem Cells Service Product and Solutions
- 2.1.4 Lonza Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Lonza Recent Developments and Future Plans
- 2.2 Thermo Fisher Scientific Inc.
- 2.2.1 Thermo Fisher Scientific Inc. Details
- 2.2.2 Thermo Fisher Scientific Inc. Major Business
- 2.2.3 Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Product and Solutions
- 2.2.4 Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
- 2.3 FUJIFILM Cellular Dynamics, Inc. (FCDI)
- 2.3.1 FUJIFILM Cellular Dynamics, Inc. (FCDI) Details
- 2.3.2 FUJIFILM Cellular Dynamics, Inc. (FCDI) Major Business
- 2.3.3 FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Product and Solutions
- 2.3.4 FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Developments and Future Plans
- 2.4 Charles River Laboratories
- 2.4.1 Charles River Laboratories Details
- 2.4.2 Charles River Laboratories Major Business
- 2.4.3 Charles River Laboratories Induced Pluripotent Stem Cells Service Product and Solutions
- 2.4.4 Charles River Laboratories Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Charles River Laboratories Recent Developments and Future Plans
- 2.5 Novo Holdings (Catalent, Inc)
- 2.5.1 Novo Holdings (Catalent, Inc) Details
- 2.5.2 Novo Holdings (Catalent, Inc) Major Business
- 2.5.3 Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Product and Solutions
- 2.5.4 Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Novo Holdings (Catalent, Inc) Recent Developments and Future Plans
- 2.6 Creative Bioarray
- 2.6.1 Creative Bioarray Details
- 2.6.2 Creative Bioarray Major Business
- 2.6.3 Creative Bioarray Induced Pluripotent Stem Cells Service Product and Solutions
- 2.6.4 Creative Bioarray Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Creative Bioarray Recent Developments and Future Plans
- 2.7 Creative Biolabs
- 2.7.1 Creative Biolabs Details
- 2.7.2 Creative Biolabs Major Business
- 2.7.3 Creative Biolabs Induced Pluripotent Stem Cells Service Product and Solutions
- 2.7.4 Creative Biolabs Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Creative Biolabs Recent Developments and Future Plans
- 2.8 iXCells Biotechnologies
- 2.8.1 iXCells Biotechnologies Details
- 2.8.2 iXCells Biotechnologies Major Business
- 2.8.3 iXCells Biotechnologies Induced Pluripotent Stem Cells Service Product and Solutions
- 2.8.4 iXCells Biotechnologies Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 iXCells Biotechnologies Recent Developments and Future Plans
- 2.9 Creative Biogene
- 2.9.1 Creative Biogene Details
- 2.9.2 Creative Biogene Major Business
- 2.9.3 Creative Biogene Induced Pluripotent Stem Cells Service Product and Solutions
- 2.9.4 Creative Biogene Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Creative Biogene Recent Developments and Future Plans
- 2.10 Axol Bioscience Ltd.
- 2.10.1 Axol Bioscience Ltd. Details
- 2.10.2 Axol Bioscience Ltd. Major Business
- 2.10.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Product and Solutions
- 2.10.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Axol Bioscience Ltd. Recent Developments and Future Plans
- 2.11 Elixirgen Scientific, Inc.
- 2.11.1 Elixirgen Scientific, Inc. Details
- 2.11.2 Elixirgen Scientific, Inc. Major Business
- 2.11.3 Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Product and Solutions
- 2.11.4 Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Elixirgen Scientific, Inc. Recent Developments and Future Plans
- 2.12 Cyagen
- 2.12.1 Cyagen Details
- 2.12.2 Cyagen Major Business
- 2.12.3 Cyagen Induced Pluripotent Stem Cells Service Product and Solutions
- 2.12.4 Cyagen Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Cyagen Recent Developments and Future Plans
- 2.13 ALSTEM
- 2.13.1 ALSTEM Details
- 2.13.2 ALSTEM Major Business
- 2.13.3 ALSTEM Induced Pluripotent Stem Cells Service Product and Solutions
- 2.13.4 ALSTEM Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 ALSTEM Recent Developments and Future Plans
- 2.14 uBriGene Biosciences International Co.
- 2.14.1 uBriGene Biosciences International Co. Details
- 2.14.2 uBriGene Biosciences International Co. Major Business
- 2.14.3 uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Product and Solutions
- 2.14.4 uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 uBriGene Biosciences International Co. Recent Developments and Future Plans
- 2.15 NEXEL Co., Ltd.
- 2.15.1 NEXEL Co., Ltd. Details
- 2.15.2 NEXEL Co., Ltd. Major Business
- 2.15.3 NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Product and Solutions
- 2.15.4 NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 NEXEL Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Induced Pluripotent Stem Cells Service Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Induced Pluripotent Stem Cells Service by Company Revenue
- 3.2.2 Top 3 Induced Pluripotent Stem Cells Service Players Market Share in 2025
- 3.2.3 Top 6 Induced Pluripotent Stem Cells Service Players Market Share in 2025
- 3.3 Induced Pluripotent Stem Cells Service Market: Overall Company Footprint Analysis
- 3.3.1 Induced Pluripotent Stem Cells Service Market: Region Footprint
- 3.3.2 Induced Pluripotent Stem Cells Service Market: Company Product Type Footprint
- 3.3.3 Induced Pluripotent Stem Cells Service Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Induced Pluripotent Stem Cells Service Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Induced Pluripotent Stem Cells Service Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Induced Pluripotent Stem Cells Service Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Induced Pluripotent Stem Cells Service Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Induced Pluripotent Stem Cells Service Consumption Value by Type (2021-2032)
- 6.2 North America Induced Pluripotent Stem Cells Service Market Size by Application (2021-2032)
- 6.3 North America Induced Pluripotent Stem Cells Service Market Size by Country
- 6.3.1 North America Induced Pluripotent Stem Cells Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Induced Pluripotent Stem Cells Service Consumption Value by Type (2021-2032)
- 7.2 Europe Induced Pluripotent Stem Cells Service Consumption Value by Application (2021-2032)
- 7.3 Europe Induced Pluripotent Stem Cells Service Market Size by Country
- 7.3.1 Europe Induced Pluripotent Stem Cells Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 7.3.3 France Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Induced Pluripotent Stem Cells Service Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Induced Pluripotent Stem Cells Service Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region
- 8.3.1 Asia-Pacific Induced Pluripotent Stem Cells Service Consumption Value by Region (2021-2032)
- 8.3.2 China Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 8.3.5 India Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Induced Pluripotent Stem Cells Service Consumption Value by Type (2021-2032)
- 9.2 South America Induced Pluripotent Stem Cells Service Consumption Value by Application (2021-2032)
- 9.3 South America Induced Pluripotent Stem Cells Service Market Size by Country
- 9.3.1 South America Induced Pluripotent Stem Cells Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Induced Pluripotent Stem Cells Service Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Induced Pluripotent Stem Cells Service Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country
- 10.3.1 Middle East & Africa Induced Pluripotent Stem Cells Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Induced Pluripotent Stem Cells Service Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Induced Pluripotent Stem Cells Service Market Drivers
- 11.2 Induced Pluripotent Stem Cells Service Market Restraints
- 11.3 Induced Pluripotent Stem Cells Service Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Induced Pluripotent Stem Cells Service Industry Chain
- 12.2 Induced Pluripotent Stem Cells Service Upstream Analysis
- 12.3 Induced Pluripotent Stem Cells Service Midstream Analysis
- 12.4 Induced Pluripotent Stem Cells Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Induced Pluripotent Stem Cells Service. Industry analysis & Market Report on Induced Pluripotent Stem Cells Service is a syndicated market report, published as Global Induced Pluripotent Stem Cells Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Induced Pluripotent Stem Cells Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
